Opus Genetics (IRD) Assets Average (2021 - 2024)
Opus Genetics (IRD) has disclosed Assets Average for 7 consecutive years, with $48.8 million as the latest value for Q3 2023.
- On a quarterly basis, Assets Average rose 200.79% to $48.8 million in Q3 2023 year-over-year; TTM through Sep 2023 was $48.8 million, a 200.79% increase, with the full-year FY2022 number at $37.5 million, changed N/A from a year prior.
- Assets Average was $48.8 million for Q3 2023 at Opus Genetics, up from $44.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $48.8 million in Q3 2023 to a low of $16.2 million in Q3 2022.
- A 3-year average of $29.3 million and a median of $24.3 million in 2021 define the central range for Assets Average.
- Peak YoY movement for Assets Average: plummeted 33.0% in 2022, then soared 200.79% in 2023.
- Opus Genetics' Assets Average stood at $24.6 million in 2021, then increased by 28.97% to $31.8 million in 2022, then soared by 53.64% to $48.8 million in 2023.
- Per Business Quant, the three most recent readings for IRD's Assets Average are $48.8 million (Q3 2023), $44.4 million (Q2 2023), and $47.2 million (Q1 2023).